Literature DB >> 26708123

Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.

Makoto Watanabe1, Yoshihiko Saito2, Kazutaka Aonuma3, Atsushi Hirayama4, Nagara Tamaki5, Hiroyuki Tsutsui6, Toyoaki Murohara7, Hisao Ogawa8, Takashi Akasaka9, Michihiro Yoshimura10, Akira Sato3, Tadateru Takayama4, Mamoru Sakakibara6, Susumu Suzuki7, Kenichi Ishigami11, Kenji Onoue1.   

Abstract

BACKGROUND: The majority of patients who undergo coronary arteriography are discharged from the hospital on the day of the procedure or on the following day. The aim of this study is to investigate whether the change in serum creatinine (SCr) and estimated glomerular filtration rate (eGFR) on the day following cardiac catheterization can predict the development of contrast-induced nephropathy (CIN).
METHODS: This is a multicenter prospective observational study, which consists of 860 patients who underwent cardiac catheterization. We measured SCr and eGFR before cardiac catheterization, on the following day, and 48-72h post-procedure. Definition of CIN is changes in SCr ≥0.5mg/dL or ≥25% from baseline 48-72h after contrast exposure.
RESULTS: CIN occurred in 40 patients. SCr levels significantly increased from a baseline of 1.55±1.08mg/dL to 1.79±1.26mg/dL on the following day in patients with CIN (p<0.0001), but significantly decreased from a baseline of 1.21±0.65mg/dL to 1.18±0.61mg/dL on the following day in those without CIN (p<0.0001). eGFR significantly decreased from a baseline of 47.3±28.3mL/min/1.73m2 to 40.6±26.7mL/min/1.73m2 on the following day in patients with CIN (p<0.0001), but significantly increased from a baseline of 53.1±22.0mg/dL to 53.6±21.2mg/dL on the following day in those without CIN (p=0.0236). Receiver operating characteristic curve analysis indicated that SCr change ≥0.1mg/dL [area under the curve (AUC)=0.852, sensitivity 72.5%, specificity 86.1%] and eGFR change ≤-1.1mL/min/1.73m2 (AUC=0.789, sensitivity 85.0%, specificity 64.9%) were the best cut-off values for predicting CIN. Multivariate logistic regression showed that a change in SCr ≥0.1mg/dL [odds ratio (OR), 29.3; 95% confidence interval (CI), 10.8-96.2] and change in eGFR ≤-1.1mL/min/1.73m2 (OR, 69.7; 95% CI, 13.3-952) were powerful independent predictors of CIN.
CONCLUSIONS: Changes in SCr and eGFR on the day following cardiac catheterization predict the development of CIN.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Change in estimated glomerular filtration rate; Change in serum creatinine level; Contrast-induced nephropathy; Prediction of contrast-induced nephropathy

Mesh:

Substances:

Year:  2015        PMID: 26708123     DOI: 10.1016/j.jjcc.2015.10.016

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  4 in total

1.  Microalbuminuria Complicated with Low Estimated Glomerular Filtration Rate: Early Risk Factors for Contrast-Induced Acute Kidney Injury After Coronary Intervention.

Authors:  Meijuan Hu; Erfei Luo; Gaoliang Yan; Chengchun Tang; Lei Wang; Qigao Zhang; Jianbin Gong
Journal:  Med Sci Monit       Date:  2022-05-23

2.  The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.

Authors:  Jingjing Zhao; Huahua Liu; Buyun Xu; Jiahao Peng; Yangbo Xing; Weiliang Tang; Fang Peng
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-27       Impact factor: 2.629

3.  Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography.

Authors:  Chin-Sung Kuo; Ruey-Hsing Chou; Ya-Wen Lu; Yi-Lin Tsai; Po-Hsun Huang; Shing-Jong Lin
Journal:  Sci Rep       Date:  2020-01-29       Impact factor: 4.379

4.  Low-Dose Scanning Technology Combined with Low-Concentration Contrast Material in Renal Computed Tomography Angiography (CTA): A Preliminary Study.

Authors:  Sulan Liu; Wei Li; Hao Shi; Huaqiang Sheng; Jingli Fan; Jingzhen He; Hongjun Sun
Journal:  Med Sci Monit       Date:  2017-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.